SAILIFENSESai Life Sciences LimitedLowNeutral
Announced Mon, 11 May · 11:31 IST

Earnings conference call invite for the quarter and year ended Financial Results ended on 31 March, 2026

Board & Shareholder Meetings View source PDF

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹1117.90
prior close
₹1131.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.1-0.7-0.9-2.9-2.0+0.1-3.9+0.9+2.8+1.1+6.4+13.5
Up moveDown movePending
AI summary

Sai Life Sciences Limited has issued a routine regulatory intimation under SEBI Listing Regulations announcing an earnings conference call scheduled for Friday, May 15, 2026 at 4:00 PM IST. The call will discuss the company's audited financial results for Q4 and the full year ended March 31, 2026 (FY26). Managing Director & CEO Krishna Kanumuri and CFO Siva Chittor will lead the discussion, providing a brief overview of earnings performance followed by an interactive Q&A session with analysts and institutional investors. The company is a CRDMO (Contract Research, Development, and Manufacturing Organization) headquartered in Hyderabad. This is a standard investor relations event and does not contain actual financial numbers.

Likely market impact

The announcement signals the company's commitment to transparency and investor engagement. No actual earnings figures are disclosed here; the call will provide the first detailed discussion of FY26 results. Retail investors should note the scheduled date to participate or review transcripts after the event.